Literature DB >> 33453034

A systematic review and meta-analysis of delayed coronary artery access for coronary angiography with or without percutaneous coronary intervention (PCI) in patients who underwent transcatheter aortic valve replacement (TAVR).

Miguel A Diaz1, Marquand Patton1, Pedro Valdes1, Jefferson L Vieira2, Amin Rmeileh1, Francisco Y Macedo3.   

Abstract

Coronary artery disease (CAD) and severe aortic valve stenosis frequently coexist. Given the progressive nature of CAD, silent or non-significant CAD may become symptomatic or functionally relevant years after TAVR. However, there is a paucity of data documenting the feasibility of either coronary angiography and/or PCI after TAVR. We systematically searched Medline, Pubmed, Embase, Cochrane database, Google Scholar, Science Direct, Web of Science, and conference abstracts from conception to March 2020 using OvidSP in TAVR patients undergoing coronary angiography with or without PCI at least 6 months after TAVR. Patients and procedural characteristics were summarized. The primary outcome of interest was successful coronary angiography for either the left main coronary artery (LMCA) or right coronary artery (RCA) with or without PCI. Pooled estimates were calculated using a random-effects meta-analysis. The study protocol was registered in PROSPERO. Eleven reports for a total of 696 coronary angiograms and 287 PCI were included in the analysis. Patients were slightly predominantly male, older and had a mean left ventricular ejection fraction of more than 50% with an intermediate STS. The summary estimate rates of successful LMCA and RCA angiography with a Medtronic self-expandable valve (SEV) were 84% (95% CI 73-90%, I2 = 79, p = 0.015) and 69% (95% CI 37-89%, I2 = 86, p = 0.23), respectively, while with the Edwards Lifesciences balloon expandable valve (BEV), the summary estimate rates for successful LMCA and RCA angiography were 94% (95% CI 72-99%, I2 = 66, p = 0.003) and 95% (95% CI 48-99%, I2 = 83, p = 0.05), respectively. The summary estimate rate of successful PCI post TAVR with either a Medtronic SEV or Edwards Lifesciences BEV was 93% (95% CI 86-96%, I2 = 33, p = 0.0001). The overall achievement of a successful coronary angiography with or without PCI in post-TAVR patients is high, with a lower success rate for RCA angiography in patients with the Medtronic SEV Mortality and bleeding did not differ in our analysis.
© 2021. Japanese Association of Cardiovascular Intervention and Therapeutics.

Entities:  

Keywords:  Aortic stenosis; Coronary angiography; Coronary artery disease; Meta-analysis; Percutaneous coronary intervention; Transcatheter aortic valve replacement; Trasnscatheter therapy

Mesh:

Year:  2021        PMID: 33453034     DOI: 10.1007/s12928-020-00753-4

Source DB:  PubMed          Journal:  Cardiovasc Interv Ther        ISSN: 1868-4297


  2 in total

1.  Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation.

Authors:  Carlo Zivelonghi; Gabriele Pesarini; Roberto Scarsini; Mattia Lunardi; Anna Piccoli; Valeria Ferrero; Leonardo Gottin; Corrado Vassanelli; Flavio Ribichini
Journal:  Am J Cardiol       Date:  2016-11-16       Impact factor: 2.778

2.  Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self-expandable bioprosthetic valve.

Authors:  Wah Wah Htun; Cindy Grines; Theodore Schreiber
Journal:  Catheter Cardiovasc Interv       Date:  2017-10-08       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.